Lipid-Lowering Efficacy and Safety of a New Generic Rosuvastatin in Koreans: an 8-Week Randomized Comparative Study with a Proprietary Rosuvastatin-Reference-Cited by-同舟云学术

Lipid-Lowering Efficacy and Safety of a New Generic Rosuvastatin in Koreans: an 8-Week Randomized Comparative Study with a Proprietary Rosuvastatin

Published:2020 Issue:2 Volume:9 Page:283
ISSN:2287-2892
Container-title:Journal of Lipid and Atherosclerosis
language:en
Short-container-title:J Lipid Atheroscler

Author:

Kim Hyoeun¹^ORCID,Lee Chan Joo²^ORCID,Choi Donghoon²^ORCID,Kim Byeong-Keuk²^ORCID,Kim In-Cheol³^ORCID,Kim Jung-Sun⁴^ORCID,Ahn Chul-Min²^ORCID,Hong Geu-Ru²^ORCID,Cho In-Jeong⁴^ORCID,Shim Chi-Young²^ORCID,Lee Sang-Hak²^ORCID

Affiliation:

1. Department of Health Promotion, Yonsei University College of Medicine, Seoul, Korea.

2. Division of Cardiology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

3. Division of Cardiology, Department of Internal Medicine, Dongsan Medical Center, Keimyung University College of Medicine, Daegu, Korea.

4. Division of Cardiology, Department of Internal Medicine, Ewha Womans University Seoul Hospital, Seoul, Korea.

Funder

Whan In Pharm Co., Ltd.

Publisher

Korean Society of Lipidology and Atherosclerosis

Link

https://e-jla.org/pdf/10.12997/jla.2020.9.2.283

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The problem of choice: original drug or generic? Emphasis on rosuvastatin;Rational Pharmacotherapy in Cardiology;2022-05-06

2. The problem of choice: original drug or generic? Emphasis on rosuvastatin;RATION PHARMACOTHER;2022

3. Assessing the Validity of the Criteria for the Extreme Risk Category of Atherosclerotic Cardiovascular Disease: A Nationwide Population-Based Study;Journal of Lipid and Atherosclerosis;2022

4. Quality Attributes Comparison of Selected Brands of Rosuvastatin Calcium Tablets Marketed in the US and Bangladesh;Journal of Pharmaceutical Research International;2021-07-29